Results 21 to 30 of about 2,807 (168)

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study

Radiation Oncology, 2020
Background The treatment for brain metastases in small cell lung cancer (SCLC) is still controversial. The purpose of this study was to compare different brain radiotherapy treatments on SCLC patients with brain metastases.
Meng Ni, Aijun Jiang, Wenju Liu, Yanxing Sheng, Haiyan Zeng, Ning Liu, Qingxiao Gao, Yong Wang, Jinming Yu, Shuanghu Yuan   +9 more
doaj   +1 more source

Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors

Frontiers in Oncology, 2021
Despite the continued controversy over defining an optimal delivery mechanism, the critical role of adjuvant radiation in the management of surgically resected primary and metastatic brain tumors remains one of the universally accepted standards in neuro-
Christopher P. Cifarelli, Christopher P. Cifarelli, Geraldine M. Jacobson   +2 more
doaj   +1 more source

Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery

Frontiers in Oncology, 2023
PurposeTo compare Whole-brain radiation therapy with simultaneous integrated boost (WBRT+SIB) to stereotactic radiosurgery (SRS)for non-small cell lung cancer (NSCLC)with brain metastases (BMs)in terms of overall survival (OS), intracranial progression ...
Xiaotao Dong, Kunlun Wang, Hui Yang, Yan Li, Yanqi Hou, Jiali Chang, Ling Yuan   +6 more
doaj   +1 more source

A Case of Malignant Peripheral Nerve Sheath Tumor of the Hypoglossal Nerve after Stereotactic Radiosurgery Treatment

Journal of Neurological Surgery Reports, 2014
Objectives Hypoglossal schwannomas are rare. Surgical resection has been the standard treatment modality. Radiosurgery has been increasingly used for treatment. Radiation-associated secondary malignancy/malignant transformation has not been documented in
Tong Yang, Gordana Juric-Sekhar, Donald Born, Laligam N. Sekhar   +3 more
doaj   +1 more source

Whole brain irradiation with simultaneous integrated boost in treatment of oligometastatic brain disease [PDF]

Vojnosanitetski Pregled, 2019
Background/Aim. Brain metastases occur in 20%–30% of all patients with systemic cancer. We aimed at investigating whether patients with oligometastatic brain disease treated with whole brain radiotherapy (WBRT) and simultaneous integrated boost of brain ...
Kolarević Goran, Jaroš Dražan, Ćazić Dejan, Đokanović Dejan   +3 more
doaj   +1 more source

Dosimetric advantages of stereotactic radiosurgery as a boost to adjuvant conventional radiotherapy in the setting of adenoid cystic carcinoma of the parotid with skull base invasion

Clinical Case Reports, 2018
Key Clinical Message This study highlights gamma knife stereotactic radiosurgery (GK‐SRS) as boost therapy in a patient with adenoid cystic carcinoma of the parotid involving the skull base and invasion of the facial nerve.
Jae L. Phan, Courtney Pollard III, He Wang, Sweet Ping Ng, Tommy Sheu, Lawrence E. Ginsberg, Amy C. Hessel, Paul W. Gidley, David I. Rosenthal, Jack Phan   +9 more
doaj   +1 more source

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases

BMC Cancer, 2005
Background An evidence-based clinical practice guideline on the optimal radiotherapeutic management of single and multiple brain metastases was developed. Methods A systematic review and meta-analysis was performed.
Wong Rebecca KS, Lloyd Nancy S, Tsao May N   +2 more
doaj   +1 more source

Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial

BMC Cancer, 2012
Background One third of all cancer patients will develop bone metastases and the vertebral column is involved in approximately 70% of these patients. Conventional radiotherapy with of 1–10 fractions and total doses of 8-30 Gy is the current standard for ...
Guckenberger Matthias, Hawkins Maria, Flentje Michael, Sweeney Reinhart A   +3 more
doaj   +1 more source

Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

Frontiers in Oncology, 2016
IntroductionThymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiosurgery and chemotherapy are often the only treatment options available to physicians.MethodsA 70-year old man presented with an unresectable Stage III thymic ...
Sarah Dooley, Carryn Marie Anderson
doaj   +1 more source

Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases

BMC Cancer, 2022
Purpose Stereotactic radiosurgery (SRS) has become a standard approach for the treatment of patients with few metastatic brain lesions. However, the optimal treatment approach for the use radiotherapy in the treatment of non-small cell lung cancer (NSCLC)
Zhengting Chen, Lingli Zhou, Min Zhao, Ke Cao, Yanqing Li, Xiaoling Liu, Yu Hou, Lan Li, Li Wang, Li Chang, Mei Yang, Wenhui Li, Yaoxiong Xia   +12 more
doaj   +1 more source